ICG Angiogram as a Predictor of Postoperative Visual Function After EEA Surgery

Conditions

• Indocyanine Green
• Skull Base Neoplasms

Eligibility Criteria

Sex

ALL

Age

18 Years - N/A

Healthy Volunteers

Not accepted

Interventions

• Indocyanine Green — PROCEDURE
  Tumor resection, direct visualization of the chiasm and both optic nerves and ICG administration will be provided as it is recommended by the standard of care. ICG will be administered by an injection of 5 mg of ICG diluted in a 10 mL syringe performed in the line closest to the heart followed by a 10-mL saline bolus. Using near-infrared lighting, the investigators will determine the time between anterior cerebral arteries (ACA) peak luminescence to the peak luminescence of the superior hypophyseal arteries enveloping the optic chiasm (ACA to chiasm time). Because luminescence of large vessels precedes small arterial penetration, signal from the ACAs was considered as "time 0" to account for possible differences in the arm-brain time between patients. In addition, the investigators will analyze the proportion of superior hypophyseal branches on the chiasm that luminesced from ICG.

Study Details

Endonasal endoscopic approaches are an established treatment for suprasellar lesions compromising the optic nerves (ON). Surgery often involves dissecting tumors from the optic nerves and its blood supply, which can result in nerve damage and visual loss after surgery. To date, there are no reliable methods to monitor the optic nerve function during surgery and thus, post-surgical visual outcomes is unknown until the patients are fully awake after surgery for a visual exam. This delay in diagnosis prevents early therapeutic measures and can result in further harm to the ON. We have recently recognized that when ICG is routinely injected during these cases to check for patency of the big arteries the sub millimetric superior hypophyseal arteries supplying (SHA) the ON are also visible and that lack of visualization of these vessels is associated with worse visual deficits after surgery. Thus, ICG may be a tool to intraoperative predict visual outcomes after endonasal approach for suprasellar lesions and fill the nondiagnostic gap. This study will assess whether endoscopic ICG angiography before and after resection of suprasellar lesions can predict post-operative visual deficits. Successful completion will provide surgeons a novel tool to assess visual function during surgery. The ICG endoscopic angiograms suggested in this study are noninvasive and currently routinely performed at the end of surgery to check for patency of big brain arteries.

Key Dates

Start date

Jul 31, 2024

Status verified

Jul 2024

Primary completion

Jul 31, 2025

Completion

Dec 31, 2025

Study Design

Enrollment

40 participants (estimated)

Arms

• Arm: ICG Group
  Eligible participants are those diagnosed with suprasellar lesions undergoing ICG angiography during endoscopic endonasal resection.

Primary Outcome Measure

Percentage of Patients with Post Operative Visual Acuity Impairment and Visual Field Defect [ Time Frame: From the surgery to first post-operative follow up (6 weeks) ]

Central Contacts

• Ezequiel Goldschmidt, MD, PhD
  415.514.6482
  [email protected]
• Daniel Quintana, BA
  9094418999
  [email protected]

Locations (1)

Find similar trials in San Francisco, CA

Related Studies

• Optic Nerve Stimulation To Prevent Visual Deficits After Endoscopic Cranial Approaches
  Not Yet Recruiting · University of California, San Francisco · San Francisco, California
• Role of Novel RADA16 Hydrogel in Endoscopic Skull Base Surgery
  Recruiting · Indiana University · Indianapolis, Indiana